Akebia Therapeutics Inc. (AKBA) gained 10.35% or 0.76 to $8.1. It is about 9.26 million shares traded, which is 1119.82% compare to the average total volume 826961. The market cap of AKBA is $946.79 million. The year to date change is 36.91%. The 52 week price range is from $5.2 to $14.33. Price of AKBA have changed -0.54% during last week. It have changed 13.27% over last month, -19.78% over last 3 months, -3.04% over last 6 months and -45.71% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for AKBA is 6.37. It is -21.36% below current price. The 200-day Moving Averages for AKBA is 8.24. It is 1.73% above current price. The 52-week High is 14.33. It is 76.91% from the current price. The 52-week Low is 5.2. It is -35.80% from current price.
There are some statistics of AKBA. It is has market cap $946.79 million. The share outstanding is 116.89 million. The average volume is 826961. The percent of top 15 Institution holding is 56.70%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of AKBA is -58.79%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of AKBA is -19.20%.